Deals channel feed – Endpoints News

Deals channel feed

AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M

6 months ago

Another Paragon offshoot inks reverse merger as Jade takes Aerovate’s place

6 months ago

Lundbeck doubled its offer for Longboard over six months, new filing shows

6 months ago

Biogen signs molecular glue deal, raises yearly projections

6 months ago

Novartis highlights overall M&A track record following MorphoSys impairment

6 months ago

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

6 months ago

Paragon launches another company in hot PD-1xVEGF space that goes straight to reverse merger

6 months ago

Corrected: Genmab lines up T cell engager pact with Revitope

6 months ago

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

6 months ago

AbbVie makes $1.4B acquisition of Alzheimer's biotech

6 months ago

Novartis pays Monte Rosa $150M for Phase 1 drug in latest endorsement of molecular glues

6 months ago

Lyell Immunopharma to acquire ImmPACT Bio, cut top programs

6 months ago

Roche returns to Dyno for its AAV tech with $50M upfront

6 months ago

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

6 months ago

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

6 months ago

Samsung Bio inks largest deal yet worth $1.24B with unnamed Asian pharma

6 months ago

Roche, Genentech end anti-tau Alzheimer’s drug collaboration with UCB

6 months ago

Consumer and union groups call on FTC to ‘challenge’ Novo-Catalent deal

6 months ago

Novartis pays $70M upfront to license Chinese biotech’s antitumor drug

6 months ago

Sanofi invests in new radioligand partner Orano Med, buying 16% stake for €300M

6 months ago

Takeda parts ways with Wave Life Sciences even with Huntington’s trial win

6 months ago

Pfizer partners with molecular glue startup Triana in $49M upfront deal

6 months ago

Eli Lilly reveals £279M investment in the UK through new government deal

6 months ago

Bausch + Lomb's stock rises following report of potential bid from private equity firms TPG and Blackstone

6 months ago

First page Previous page 7 8 91011 12 13 Next page Last page